1. Home
  2. ALDX vs ATNI Comparison

ALDX vs ATNI Comparison

Compare ALDX & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • ATNI
  • Stock Information
  • Founded
  • ALDX 2004
  • ATNI 1987
  • Country
  • ALDX United States
  • ATNI United States
  • Employees
  • ALDX N/A
  • ATNI N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • ATNI Telecommunications Equipment
  • Sector
  • ALDX Health Care
  • ATNI Telecommunications
  • Exchange
  • ALDX Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • ALDX 304.9M
  • ATNI 335.2M
  • IPO Year
  • ALDX 2014
  • ATNI 1991
  • Fundamental
  • Price
  • ALDX $6.58
  • ATNI $22.79
  • Analyst Decision
  • ALDX Strong Buy
  • ATNI Strong Buy
  • Analyst Count
  • ALDX 2
  • ATNI 2
  • Target Price
  • ALDX $10.00
  • ATNI $31.00
  • AVG Volume (30 Days)
  • ALDX 666.8K
  • ATNI 82.0K
  • Earning Date
  • ALDX 05-01-2025
  • ATNI 03-04-2025
  • Dividend Yield
  • ALDX N/A
  • ATNI 4.39%
  • EPS Growth
  • ALDX N/A
  • ATNI N/A
  • EPS
  • ALDX N/A
  • ATNI N/A
  • Revenue
  • ALDX N/A
  • ATNI $729,075,000.00
  • Revenue This Year
  • ALDX N/A
  • ATNI $3.02
  • Revenue Next Year
  • ALDX N/A
  • ATNI $0.27
  • P/E Ratio
  • ALDX N/A
  • ATNI N/A
  • Revenue Growth
  • ALDX N/A
  • ATNI N/A
  • 52 Week Low
  • ALDX $2.75
  • ATNI $14.74
  • 52 Week High
  • ALDX $7.20
  • ATNI $33.72
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 53.63
  • ATNI 69.67
  • Support Level
  • ALDX $6.22
  • ATNI $21.74
  • Resistance Level
  • ALDX $6.87
  • ATNI $23.60
  • Average True Range (ATR)
  • ALDX 0.46
  • ATNI 1.23
  • MACD
  • ALDX -0.03
  • ATNI 0.24
  • Stochastic Oscillator
  • ALDX 60.51
  • ATNI 88.89

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise US Telecom and International Telecom. The company earns revenue from its telecommunication services.

Share on Social Networks: